medigraphic.com
SPANISH

Gaceta Médica de México

ISSN 0016-3813 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2006, Number 3

<< Back Next >>

Gac Med Mex 2006; 142 (3)

A 32 years old man with multiple endocrine disease.

González-Virla B, Vargas-Ortega G, López-Tarabay C
Full text How to cite this article

Language: Spanish
References: 15
Page: 239-242
PDF size: 507.62 Kb.


Key words:

No keywords

Text Extraction

No abstract


REFERENCES

  1. Hayes FJ, Seminara SB, Crowley WF. Hypogonadotropic hypogonadism. Endocrinol Metab Clin North Am 1998;27:739-763.

  2. Pitteloud N, Hayes FJ, Boepple PA, et al. The role of prior pubertad development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2002;87:152-160.

  3. Seminara SB, Hayes FJ, Crowley WF. Gonadotropin-releasing hormone deficiency in the human (Idiopathic hypogonadotropic hypogonadism and Kallmann’s syndrome): Pathophysiological and genetic considerations. Endocr Rev 1998;19:521-539.

  4. Spratt DI, Carr DB, Merriam GR, et al. The spectrum of abnormal patterns of gonadotropin-releasing hormona secretion in men with idiopathic hypogonadotropic hypogonadism: clinical and laboratory correlations. J Clin Endocrinol Metab 1987;64:283-291.

  5. Nachtigall LB, Boepple PA, Pralong FP, et al. Adult-onset idiopathic hypogonadism hypogonadotropic a treatable form of male infertility. N Engl J Med 1997;336:410-415.

  6. Bick D, Franco B, Sherins RJ. Brief report: intragenic deletion of the KALIG-1 gene in Kallmann´s syndrome. N Engl J Med 1992;326:1752-1755.

  7. Bizarro A, Valentini G, Di Marino, et al. Influence of testosterone therapy on clinical an immunological features of autoimmune diseases associated with Klinefelter´s syndrome. J Clin Endocrinol Metab 1987;64:32-36.

  8. Cutolo M, Balleari E, Giusti M et al. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1-5.

  9. Tripathy D, Dhindsa S, Garg R et al. Hypogonadotrophic hypogonadism in erectile dysfunction associated with type 2 diabetes mellitus: a common defect?. Metabol Syndr Relat Disord 2003;1:75-81.

  10. Bruning JC, Gautam D, Burks DJ et al. Role of brain insulin receptor in control of body weight and reproduction. Science 2000;289:2122-2125.

  11. Zeki Yesilova, Metin Ozata, Ismail H. Kocar et al. The effects of gonadotropin treatment on the inmunological features of male patients with idiopathic hypogonadotrophic hypogonadism. J Clin Endocrinol Metab 2000;85:66-70.

  12. Oliveira LMB, Seminara SB, Beranova M, et al. The importance of autosomal genes in Kallmann syndrome: Genotype-Phenotype correlations and neuroendocrine characteristics. J Clin Endocrinol Metab 2001;86:1532-1538.

  13. Weinstein Y, Berkovich Z. Testosterone effect on bone marrow, thymus and suppressor T cells in the (BZB x NZW)F1 mice: Its relevance to autoimmunity. J Immunol. 1981;126:998-1002.

  14. Cutolo M, Sulli A, Seriolo B. et al. Estrogen, the immune response and autoimmunity. Clin Exp Rheumatol. 1995;13:217-226.

  15. Naoko K, Tesuya T, Kunihiko T. Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:1703-1711.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Gac Med Mex. 2006;142